Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.

At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

As of Friday, January 09, Mirion Technologies, Inc.’s MIR share price has surged by 9.60%, which has investors questioning if this is right time to sell.

Significantly more facilities prescribe single-fraction stereotactic body radiation therapy than they did 20 years ago, but a minimal number of individuals with non-small cell lung cancer actually ...

An investigation by Howard Center for Investigative Journalism at Arizona State University and Scripps News reveals how the ...

Learn more about whether Mirion Technologies, Inc. or Nayax Ltd. is a better investment based on AAII's A+ Investor grades, ...

The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...

By all measures, Dr. Tim Williams should not be alive. Williams, 69, has survived a fall while home alone, a brain bleed, a ...

Despite a decade cancer-free, a new breast cancer diagnosis led to a bilateral mastectomy and later chemotherapy and ...

Explore how claudin-18.2 can transform cancer treatment for gastric and pancreatic tumours using targeted radiotherapy.